의료용 폴리머 시장 예측(-2030년) : 제품 유형, 제조 프로세스, 용도, 지역별 세계 분석

According to Stratistics MRC, the Global Medical Polymers Market is accounted for $41.3 billion in 2024 and is expected to reach $68.2 billion by 2030 growing at a CAGR of 8.7% during the forecast period. Medical polymers are specialty materials utilized in drug delivery systems, packaging, implants, and medical equipment. These polymers provide durability, flexibility, and biocompatibility. They include silicone, polyethylene, polypropylene, and biodegradable varieties. They are essential to the production of surgical equipment, prosthesis, catheters, and pharmaceutical packaging. They are crucial to modern medicine because of their lightweight design, chemical resistance, and sterilizability, which guarantee patient safety, effectiveness, and better results in a range of medical applications.

According to PMC studies, the US consumes around 40% of medical devices manufactured globally, followed by Europe and Japan.

Market Dynamics:

Driver:

Rising demand for medical devices and implants

The increasing prevalence of chronic diseases and aging population is driving substantial growth in the medical devices and implants sector. The surge in demand for sophisticated medical tools, apparatus, and implants has directly boosted the medical polymers market. Advanced polymer technology has enabled the creation of cutting-edge medical devices that ensure biocompatibility, resilience, and straightforward sterilization procedures in medical environments, making them essential for modern healthcare delivery.

Restraint:

High cost of raw materials

The elevated production costs of medical polymers pose significant challenges to market growth. The manufacturing processes require specialized equipment, skilled labor, and considerable energy input, while raw materials are often rare and expensive. The production costs can be up to five times higher than conventional polymers, making them economically challenging for many applications and limiting widespread adoption across cost-sensitive sectors.

Opportunity:

Expanding applications in drug delivery

The growth in biopharmaceuticals and personalized medicine has created significant opportunities for polymer-based drug delivery systems. Advanced polymeric formulations enable controlled and prolonged release of medications, enhancing treatment efficacy and patient adherence. The integration of novel technologies like 3D printing and nanotechnology is improving the precision and customization of drug formulations, driving investment in research and development.

Threat:

Product liability and recall risks

Medical devices face approximately 30% increased risk of recalls following modifications and supplements to their original design. The complexity of polymer-based medical devices and stringent regulatory requirements create significant liability risks. Recent studies linking certain polymers to adverse health effects have raised safety concerns, potentially impacting market growth and requiring manufacturers to maintain rigorous quality control measures.

Covid-19 Impact:

The Covid-19 pandemic had a positive impact on the medical polymers market, primarily driven by increased demand for single-use syringes for vaccinations. The thriving pharmaceutical industry contributed significantly to market growth through elevated requirements for medication packaging. The global threat of infectious diseases highlighted the importance of medical polymers in healthcare applications, accelerating market expansion.

The non-biodegradable polymers segment is expected to be the largest during the forecast period

The non-biodegradable polymers segment is expected to account for the largest market share during the forecast period due to their superior durability, chemical resistance, and established manufacturing processes. These materials are extensively used in long-term medical devices, surgical instruments, and medical packaging applications. Their reliability, coupled with proven performance in critical medical applications, has made them the preferred choice for healthcare providers and medical device manufacturers, ensuring their continued market leadership.

The tissue engineering & regenerative medicine segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the tissue engineering & regenerative medicine segment is predicted to witness the highest growth rate due to technological advancements and increasing investment in biotechnology. The development of innovative polymer-based scaffolds and matrices for tissue regeneration has opened new possibilities in regenerative medicine. This segment's expansion is further supported by growing research activities and the rising demand for advanced healing solutions.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share driven by extensive healthcare infrastructure and high adoption of advanced medical technologies. The region's dominance is reinforced by significant government initiatives like the Affordable Care Act and Medicaid, which have expanded healthcare access and increased demand for medical devices and pharmaceutical packaging.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by rapid healthcare sector expansion and increasing medical tourism. Countries like Thailand, Singapore, and India are emerging as major medical tourism destinations, fueling demand for sophisticated medical devices and implants. The region's growth is further supported by government initiatives and increasing healthcare expenditure.

Key players in the market

Some of the key players in Medical Polymers Market include Medtronic PLC, Johnson & Johnson, DowDuPont, BASF SE, Evonik Industries AG, Covestro AG, Asahi Kasei Corporation, DSM, Mitsubishi Chemical Corporation, Lubrizol Corporation, SABIC, Solvay S.A., Arkema S.A., Celanese Corporation, Eastman Chemical Company, Kraton Corporation, Tekni-Plex, Inc. and Victrex plc.

Key Developments:

In October 2024, The Japanese technology company Asahi Kasei signed a memorandum of understanding (MOU) with Aquafil S.p.A., an Italian manufacturer of polyamide 6 (PA6). The two companies agreed to develop a novel material for 3D printing (3DP) applications utilizing Aquafil's ECONYL(R) Polymer chemically recycled PA6 and Asahi Kasei's cellulose nanofiber (CNF), with the support of ITOCHU Corporation, which has made a capital investment in Aquafil. Pellets or filaments of this compound achieve superior formability and strength, which make them suitable for use in automotive and aeronautical applications.

In September 2024, Evonik has officially opened a new facility for drying aqueous dispersions of EUDRAGIT(R) polymers at its site in Darmstadt. The new double-digit million-euro excipient manufacturing facility enables Evonik to meet the increasing demand from pharmaceutical customers for oral drug delivery solutions. By expanding production capacities, Evonik is improving supply security and shortening delivery times for EUDRAGIT(R) polymers. The new plant also operates using green electricity and steam generated from local waste incineration, saving more than 1,000 tons of CO2 equivalents per year.

In October 2023, BASF changed its European direct business for Ultraform(R) (POM) and transfer the sales process to its long-standing trusted trading partners, ALBIS and Ultrapolymers Group. Ultraform(R) is and will remain an important part of BASF's engineering plastics portfolio. By maintaining research and development for Ultraform(R) within BASF, customers will continue to benefit from BASF's innovations and broad expertise, especially in solving technical challenges.

Product Types Covered:

• Biodegradable Polymers
• Non-biodegradable Polymers

Manufacturing Process Covered:

• Primary Processing
• Advanced Processing

Applications Covered:

• Medical Disposables
• Medical Devices & Equipment
• Drug Delivery Systems
• Prosthetics & Orthotics
• Tissue Engineering & Regenerative Medicine
• Diagnostic Instruments & Tools
• Medical Packaging

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Medical Polymers Market, By Product Type

• 5.1 Introduction
• 5.2 Biodegradable Polymers
  • 5.2.1 Polylactic Acid (PLA)
  • 5.2.2 Polyhydroxyalkanoates (PHA)
  • 5.2.3 Other Biodegradable Polymers
• 5.3 Non-biodegradable Polymers
  • 5.3.1 Commodity Polymers
    • 5.3.1.1 Polypropylene (PP)
    • 5.3.1.2 Polyethylene (PE)
    • 5.3.1.3 Polyvinyl Chloride (PVC)
    • 5.3.1.4 Polystyrene (PS)
  • 5.3.2 Engineering Resins
    • 5.3.2.1 Polyurethane (PU)
    • 5.3.2.2 Polymethyl Methacrylate (PMMA)
    • 5.3.2.3 Polycarbonate (PC)
    • 5.3.2.4 Other Engineering Resins
  • 5.3.3 Medical Elastomers
    • 5.3.3.1 Thermoplastic Elastomers (TPE)
    • 5.3.3.2 Silicone Elastomers
    • 5.3.3.3 Styrenic Block Copolymers
  • 5.3.4 High-Performance Polymers
    • 5.3.4.1 PEEK (Polyether Ether Ketone)
    • 5.3.4.2 PEI (Polyetherimide)
    • 5.3.4.3 PPSU (Polyphenylsulfone)
    • 5.3.4.4 Liquid Crystal Polymers (LCPs)

6 Global Medical Polymers Market, By Manufacturing Process

• 6.1 Introduction
• 6.2 Primary Processing
  • 6.2.1 Injection Molding
  • 6.2.2 Extrusion
  • 6.2.3 Compression Molding
  • 6.2.4 Blow Molding
  • 6.2.5 Cast Molding
• 6.3 Advanced Processing
  • 6.3.1 3D Printing
  • 6.3.2 Thermoforming
  • 6.3.3 Surface Treatment
  • 6.3.4 Joining Techniques

7 Global Medical Polymers Market, By Application

• 7.1 Introduction
• 7.2 Medical Disposables
• 7.3 Medical Devices & Equipment
• 7.4 Drug Delivery Systems
• 7.5 Prosthetics & Orthotics
• 7.6 Tissue Engineering & Regenerative Medicine
• 7.7 Diagnostic Instruments & Tools
• 7.8 Medical Packaging

8 Global Medical Polymers Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 Medtronic PLC
• 10.2 Johnson & Johnson
• 10.3 DowDuPont
• 10.4 BASF SE
• 10.5 Evonik Industries AG
• 10.6 Covestro AG
• 10.7 Asahi Kasei Corporation
• 10.8 DSM
• 10.9 Mitsubishi Chemical Corporation
• 10.10 Lubrizol Corporation
• 10.11 SABIC
• 10.12 Solvay S.A.
• 10.13 Arkema S.A.
• 10.14 Celanese Corporation
• 10.15 Eastman Chemical Company
• 10.16 Kraton Corporation
• 10.17 Tekni-Plex, Inc.
• 10.18 Victrex plc